Skip to main content
Colorado General AssemblyToggle Main Menu
Agency NameToggle Agency Menu
SB25-164

Opioid Antagonist Availability & State Board of Health

Concerning opioid antagonists with a primary focus on the youth opioid epidemic, and, in connection therewith, clarifying requirements for school policies about possession and administration of opioid antagonists, requiring the state board of health to determine who a prescriber may prescribe or dispense an opioid antagonist to, and requiring the state board to consult with the Colorado youth advisory council on issues relating to the youth opioid epidemic.
Session:
2025 Regular Session
Subjects:
Education & School Finance (Pre & K-12)
Public Health
Bill Summary

The bill requires the state board of health (board) to allow the Colorado youth advisory council to present to the board twice a year on issues regarding the youth opioid epidemic and other health issues. The bill also requires the board to consult the council when the board engages in its rule-making authority regarding opioid antagonists.

Under current law, a school district, the state charter school institute, or a governing board of a nonpublic school may adopt and implement a policy that allows:

  • A school to acquire and maintain a stock supply of opioid antagonists on school grounds or on a school bus;
  • A school employee or agent who has received relevant training to administer an opioid antagonist to a person who is at risk of experiencing an opioid-related overdose; and
  • A school employee or agent to furnish an opioid antagonist to any individual, including a student, if the student has received relevant training.

The bill:

  • Permits a school to maintain an opioid antagonist in an automated external defibrillator or defibrillator cabinet in the school or on a school bus;
  • Repeals the requirement that a school employee or agent must receive training prior to administering an opioid antagonist; and
  • Creates an exception that a school employee or agent may furnish an opioid antagonist to a student who has not received relevant training if the employee or agent believes that the student is in a position to assist an individual who is suffering from an opioid-related drug overdose event or who is at risk of experiencing an opioid-related drug overdose event.

Current law provides a specific list of eligible entities that a prescriber may prescribe or dispense an opioid antagonist to. The bill eliminates the specific list and instead requires the state board of health to establish a list of eligible entities that a prescriber may prescribe or dispense an opioid antagonist to.

The bill creates a standing order allowing all eligible entities to distribute opioid antagonists.

The bill requires the department of public health and environment to furnish a report detailing youth overdose prevention during "SMART Act" hearings.


(Note: This summary applies to this bill as introduced.)

Status

Introduced
Under Consideration

Menu

Bill Text

Sponsors

Sponsor Type Legislators
Prime Sponsor

Sen. F. Winter
Rep. J. Jackson

Sponsor

Co-sponsor

The effective date for bills enacted without a safety clause is August 6, 2025, if the General Assembly adjourns sine die on May 7, 2025 (unless otherwise specified). Details

Our website is currently undergoing a redesign in order to provide a better experience for everyone. View the Beta site